14-87939921-A-G
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP2PP3_Strong
The NM_000153.4(GALC):c.1895T>C(p.Leu632Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000124 in 1,608,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. L632L) has been classified as Likely benign.
Frequency
Consequence
NM_000153.4 missense
Scores
Clinical Significance
Conservation
Publications
- Krabbe diseaseInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Myriad Women’s Health, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000153.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALC | NM_000153.4 | MANE Select | c.1895T>C | p.Leu632Pro | missense | Exon 16 of 17 | NP_000144.2 | ||
| GALC | NM_001201401.2 | c.1826T>C | p.Leu609Pro | missense | Exon 15 of 16 | NP_001188330.1 | |||
| GALC | NM_001201402.2 | c.1817T>C | p.Leu606Pro | missense | Exon 16 of 17 | NP_001188331.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALC | ENST00000261304.7 | TSL:1 MANE Select | c.1895T>C | p.Leu632Pro | missense | Exon 16 of 17 | ENSP00000261304.2 | ||
| GALC | ENST00000393568.8 | TSL:2 | c.1826T>C | p.Leu609Pro | missense | Exon 15 of 16 | ENSP00000377198.4 | ||
| GALC | ENST00000393569.6 | TSL:2 | c.1817T>C | p.Leu606Pro | missense | Exon 16 of 17 | ENSP00000377199.2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151942Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000402 AC: 1AN: 248836 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1456866Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 725090 show subpopulations
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151942Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74200 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: GALC c.1895T>C (p.Leu632Pro) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 248836 control chromosomes. c.1895T>C has been reported in the literature in at least two individuals affected with Krabbe Disease (e.g. Orsini_2016, Beltran-Quintero_2019). One individual was found only to be heterozygous, and the other individual was found to be compound heterozygous with a pathogenic variant (p.Arg210*). These data suggest that the variant may be associated with disease, but do not allow any definitive conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function (Saavedra-Matiz_2016). The most pronounced variant effect results in 10%-<30% of normal activity. The following publications have been ascertained in the context of this evaluation (PMID: 30777126, 26795590, 27638593). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Galactosylceramide beta-galactosidase deficiency Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at